Yemen launches campaign to vaccinate 1.3 million children against polio resurgence
Nearly 7,000 health teams will administer oral vaccines door-to-door or at health facilities, focusing on 120 high-risk districts, reports Xinhua, quoting the state-run Saba news agency.
The drive, targeting 1.35 million children across 12 provinces under the government's control, came as data from the World Health Organization and UNICEF showed that 282 variant polio cases have been reported in the country since 2021, 98 per cent of which in children under the age of 5, with national polio immunisation coverage dropping to 46 per cent in 2023 amid war-disrupted healthcare.
"Yemen remains at high risk for poliovirus outbreaks due to protracted conflict, weakened health systems and low routine immunisation coverage," said Acting WHO Representative in Yemen Ferima Coulbibaly-Zerbo in a joint statement issued by the WHO and UNICEF.
"With poliovirus continuing to circulate and cases confirmed in 2025, these campaigns are essential to interrupt transmission and protect every child from the debilitating effects of polio," she said.
"With confirmed cases of polio among Yemeni children, an imminent threat persists, especially for every unvaccinated child. But, through vaccination, we can keep our children safe," UNICEF Representative to Yemen Peter Hawkins said in the statement.
Yemen has been engulfed in conflict since 2014 when Houthi forces seized control of the capital Sanaa and much of the country's north, prompting a Saudi-led coalition to intervene in support of the internationally recognised government in 2015.
The conflict has created one of the world's worst humanitarian crises, with millions of Yemenis facing food insecurity and lacking access to basic services. Multiple rounds of peace talks have failed to produce a political settlement.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
First Post
21 minutes ago
- First Post
Israeli missile malfunction kills eight, including six children
According to Ahmed Abu Saifan, an emergency physician at Al-Awda Hospital, the strike hit a water distribution point in the Nuseirat refugee camp, killing six children and injuring 17 others read more Smoke rises from Gaza after an explosion, as seen from the Israeli side of the Israel-Gaza border. File image/ Reuters At least eight Palestinians, most of them children, were killed and more than a dozen others wounded in central Gaza on Sunday, in what the Israeli military said was a missile strike that missed its intended target due to a malfunction. The Israel Defence Forces (IDF) said it had been aiming at an Islamic Jihad militant in the area when the missile fell 'dozens of metres from the target.' 'The IDF regrets any harm to uninvolved civilians,' the military said in a statement, adding that the incident was under review. STORY CONTINUES BELOW THIS AD According to Ahmed Abu Saifan, an emergency physician at Al-Awda Hospital, the strike hit a water distribution point in the Nuseirat refugee camp, killing six children and injuring 17 others. Fuel shortages in Gaza have led to the closure of desalination and sanitation facilities in recent weeks, worsening the enclave's water crisis and making residents dependent on collection centres for basic supplies. In a separate attack on Sunday, Palestinian media reported that a well-known hospital consultant was among 12 people killed in an Israeli strike on a busy market in Gaza City. The health ministry in Gaza said more than 58,000 Palestinians have been killed since the war between Israel and Hamas began in October 2023. The ministry added that 139 people had been killed in the past 24 hours alone. While it does not distinguish between civilians and combatants, it said more than half of the dead were women and children. No breakthrough in ceasefire talks Efforts to reach a ceasefire remained stalled over the weekend, with both sides blaming each other for the lack of progress. Talks based on a US proposal for a 60-day pause in fighting are being held in Doha, but sources familiar with the negotiations say the two sides remain far apart on issues including the scope of an Israeli troop withdrawal from Gaza. The war began on 7 October 2023, when Hamas-led militants entered Israel, killing about 1,200 people and taking 251 hostages into Gaza. At least 20 of the remaining 50 hostages are believed to still be alive. STORY CONTINUES BELOW THIS AD Israel's campaign to defeat Hamas has displaced nearly the entire population of Gaza, which exceeds 2 million people. But Gazans say there is no safe place left in the coastal territory. On Sunday morning, a missile hit a house in Gaza City where a family had moved after being ordered to evacuate their home in the south. 'My aunt, her husband and the children, are gone. What is the fault of the children who died in an ugly bloody massacre at dawn?' said Anas Matar, speaking amid the rubble. 'They came here, and they were hit. There is no safe place in Gaza,' he said. With inputs from Reuters
Hans India
9 hours ago
- Hans India
Yemen launches campaign to vaccinate 1.3 million children against polio resurgence
Aden, July 13: Yemen's internationally recognised government has launched a three-day polio vaccination campaign, as the war-ravaged country is battling a resurgence of the disease, according to local media reports. Nearly 7,000 health teams will administer oral vaccines door-to-door or at health facilities, focusing on 120 high-risk districts, reports Xinhua, quoting the state-run Saba news agency. The drive, targeting 1.35 million children across 12 provinces under the government's control, came as data from the World Health Organization and UNICEF showed that 282 variant polio cases have been reported in the country since 2021, 98 per cent of which in children under the age of 5, with national polio immunisation coverage dropping to 46 per cent in 2023 amid war-disrupted healthcare. "Yemen remains at high risk for poliovirus outbreaks due to protracted conflict, weakened health systems and low routine immunisation coverage," said Acting WHO Representative in Yemen Ferima Coulbibaly-Zerbo in a joint statement issued by the WHO and UNICEF. "With poliovirus continuing to circulate and cases confirmed in 2025, these campaigns are essential to interrupt transmission and protect every child from the debilitating effects of polio," she said. "With confirmed cases of polio among Yemeni children, an imminent threat persists, especially for every unvaccinated child. But, through vaccination, we can keep our children safe," UNICEF Representative to Yemen Peter Hawkins said in the statement. Yemen has been engulfed in conflict since 2014 when Houthi forces seized control of the capital Sanaa and much of the country's north, prompting a Saudi-led coalition to intervene in support of the internationally recognised government in 2015. The conflict has created one of the world's worst humanitarian crises, with millions of Yemenis facing food insecurity and lacking access to basic services. Multiple rounds of peace talks have failed to produce a political settlement.
&w=3840&q=100)
Business Standard
10 hours ago
- Business Standard
WHO issues first global clinical guide on mosquito-borne diseases: Details
The World Health Organization (WHO) has released its first-ever integrated guidelines on the clinical management of arboviral diseases, including dengue, chikungunya, Zika, and yellow fever in a major step towards strengthening global response to mosquito-borne viral diseases. The new guidelines, launched earlier this month, aim to help frontline healthcare providers and hospitals manage both mild and severe cases of these diseases using standardised, evidence-based protocols. With arboviral infections posing a growing threat across tropical and subtropical regions, the WHO said the guidelines would also support policymakers and health administrators in boosting epidemic and pandemic preparedness. What are arboviral diseases? According to WHO, arboviral diseases are most commonly transmitted by Aedes mosquitoes. These include dengue, chikungunya, Zika, and yellow fever. The Aedes aegypti mosquito is capable of spreading multiple viruses in the same region, often at the same time. These infections affect more than half of the global population, with over 5.6 billion people currently at risk. The diseases often begin with flu-like symptoms such as fever, joint pain, and rash, making clinical diagnosis difficult in the absence of laboratory tests. In some cases, complications can be severe or life-threatening. Why WHO's integrated guidelines on arboviral diseases are needed According to WHO, outbreaks of arboviral diseases are becoming more frequent, widespread, and severe, driven by a combination of ecological, social, and economic factors. As a result, the geographical range of these infections is expanding rapidly. The clinical challenge is compounded by the fact that dengue, chikungunya, Zika, and yellow fever often begin with similar early symptoms making it difficult to distinguish between them, especially in regions where diagnostic tools are limited. In some areas, multiple arboviruses may be circulating at the same time. In this context, the WHO guidelines offer a unified, evidence-based approach to diagnosis and care. They are also intended as a practical reference for policymakers, health system leaders, and hospital administrators in developing national and regional preparedness strategies for future outbreaks and pandemics. Key recommendations by WHO According to WHO, the new guidelines offer clinical management protocols for four of the most common and widespread arboviral infections in humans: dengue, chikungunya, Zika, and yellow fever. For patients with non-severe, suspected or confirmed arboviral disease: Use protocolised oral fluid treatment to prevent dehydration Use paracetamol or metamizole for treating pain or fever Avoid non-steroidal anti-inflammatory medications (NSAIDs), irrespective of severity Avoid corticosteroids in non-severe cases Use crystalloid fluids (not colloids) for intravenous hydration Monitor capillary refill time and lactate levels to guide fluid management Use passive leg raise test in patients with shock to assess fluid responsiveness Avoid corticosteroids and immunoglobulin therapies in severe cases Avoid platelet transfusion in patients with low platelet counts unless active bleeding is present Use intravenous N-acetylcysteine in cases of liver failure caused by yellow fever Use experimental therapies like monoclonal immunoglobulin TY014 and sofosbuvir for yellow fever only in research settings The WHO noted that the recommendations are based on the latest available evidence and will be updated as new data emerges. These guidelines are seen as a critical step in harmonising care and improving outcomes in regions where arboviral diseases are endemic or emerging.
